The concert tour celebrates the golden age of jazz with swoon worthy hits and sentimental serenades featuring Benny ...

Bristol Myers Squibb will pay T-cell engager company Janux Therapeutics $50 million in the near term as part of a collaboration to work on a novel tumor-activated therapeutic. The resulting candidate ...

- Preliminary unaudited Q4 and Full Year 2025 net Attruby ® product revenue of $146.0 million and $362.4 million, respectively - Attruby (acoramidis) is rapidly becoming the first-choice therapy for ...

EMERYVILLE, CA, UNITED STATES, January 6, 2026 / EINPresswire.com / — Abalone Bio, a therapeutics biotech company that uniquely measures and leverages large-scale activity datasets to discover rare ...

When it comes to producing human mesenchymal stem cells (MSCs) derived from cord blood, some media perform significantly better than others, affecting process robustness as well as batch costs. In a ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment ...

GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...

Recipharm Advanced Bio, a segment of CDMO Recipharm, and Infant Bacterial Therapeutics (IBT) began a process performance qualification (PPQ) for IBT’s lead product, IBP-9414. The PPQ program will take ...

Antony Koblish, CEO, emphasized the company's continued execution on expanding its commercial footprint, improving operating discipline, and strengthening its patient-centric culture. TELA Bio ...

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care ...